A feasibility study to inform the design of a randomized controlled trial to identify the most clinically and cost effective Anticoagulation Length with low molecular weight heparin In the treatment of Cancer Associated Thrombosis (ALICAT): study protocol for a mixed-methods study

BACKGROUND: Venous thromboembolism is common in patients with cancer and requires anticoagulation with low molecular weight heparin. Current data informs anticoagulation as far as six months, yet guidelines recommend anticoagulation beyond six months in patients who have locally advanced or metastat...

Szczegółowa specyfikacja

Zapisane w:
Opis bibliograficzny
Główni autorzy: Smith, Joanna D, Baillie, Jessica, Baglin, Trevor, Griffiths, Gareth O, Casbard, Angela, Cohen, David, Fitzmaurice, David A, Hood, Kerenza, Rose, Peter, Cohen, Alexander T, Johnson, Miriam, Maraveyas, Anthony, Bell, John, Toone, Harold, Nelson, Annmarie, Noble, Simon I
Format: Artigo
Język:Inglês
Wydane: BioMed Central 2014
Hasła przedmiotowe:
Study Protocol
Dostęp online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4003288/
https://ncbi.nlm.nih.gov/pubmed/24726032
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1745-6215-15-122
Etykiety: Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!

Podobne zapisy